神经外科医师大会系统综述与循证指南:影像学在前庭神经鞘瘤诊断与管理中的作用
该指南由神经外科医师大会制定,采用系统综述与循证方法,针对前庭神经鞘瘤影像学提出7个问题并给出推荐。推荐涉及MRI序列选择(术前检测用高分辨率T2与增强T1,术后评估用增强3D T1 MPRAGE)、面神经成像、随访频率、囊性肿瘤行为、内听道侧方受累、NF2患者成像及术后随访时长,推荐等级多为Level 3,术后评估为Level 2。
要点
- 术前检测前庭神经鞘瘤应使用高分辨率T2加权和增强T1加权MRI(Level 3)。
- 术后评估应使用增强3D T1 MPRAGE,结节样强化考虑复发可疑(Level 2)。
- 内听道侧方受累程度影响面神经和听力结局,报告时应强调(Level 3)。
核心结论
- 指南基于系统综述证据,对前庭神经鞘瘤影像学诊断与管理提出多项推荐,多数为Level 3,术后评估使用增强3D T1 MPRAGE为Level 2推荐。
研究设计与样本
- 神经外科医师大会制定的系统综述与循证指南,针对7个临床问题,目标人群为成人前庭神经鞘瘤患者,证据分级采用Level 1至Level 3。
关键影像表现/征象
- 囊性前庭神经鞘瘤可能更常与快速生长、完全切除率较低相关,且术后即刻面神经结局可能较差,但随时间推移与非囊性肿瘤相似。
- 肿瘤对内听道侧方受累程度对面神经和听力结局有不良影响,阅片时应强调用于术前规划。
诊断标准与关键数值
- 初始术前评估:检测前庭神经鞘瘤的影像应使用高分辨率T2加权和增强T1加权MRI(Level 3)。
- 术前评估:标准T1、T2、FLAIR和DWI序列(轴位、冠状位和矢状位)可用于检测前庭神经鞘瘤(Level 3)。
- 术前监测:随访肿瘤生长应使用增强3D T1 MPRAGE或高分辨率T2(包括CISS或FIESTA序列)MRI(Level 3)。
- 术后评估:应使用增强3D T1 MPRAGE,结节样强化考虑复发可疑(Level 2)。
- 面神经检测:T2加权MRI可用于增强面神经走行显示,作为术前评估的一部分(Level 3)。
临床应用与阅片要点
- 对于疑似前庭神经鞘瘤的成人,初始影像应包含高分辨率T2加权和增强T1加权MRI(Level 3)。
- 术后随访评估应使用增强3D T1 MPRAGE,报告中结节样强化需提示复发可疑(Level 2)。
- 囊性前庭神经鞘瘤患者应被告知肿瘤可能更常与快速生长、完全切除率较低相关,术后即刻面神经结局可能较差但长期与非囊性相似(Level 3)。
- 解读影像用于术前规划时,应强调肿瘤对内听道侧方受累的程度(Level 3)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
QUESTION 1: What sequences should be obtained on magnetic resonance imaging (MRI) to evaluate vestibular schwannomas before and after surgery?
TARGET POPULATION: Adults with vestibular schwannomas.
RECOMMENDATIONS: Initial Preoperative Evaluation Level 3: Imaging used to detect vestibular schwannomas should use high-resolution T2-weighted and contrast-enhanced T1-weighted MRI. Level 3: Standard T1, T2, fluid attenuated inversion recovery, and diffusion weighted imaging MR sequences obtained in axial, coronal, and sagittal plane may be used for detection of vestibular schwannomas. Preoperative Surveillance Level 3: Preoperative surveillance for growth of a vestibular schwannoma should be followed with either contrast-enhanced 3-dimensional (3-D) T1 magnetization prepared rapid acquisition gradient echo (MPRAGE) or high-resolution T2 (including constructive interference in steady state [CISS] or fast imaging employing steady-state acquisition [FIESTA] sequences) MRI. Postoperative Evaluation Level 2: Postoperative evaluation should be performed with postcontrast 3-D T1 MPRAGE, with nodular enhancement considered suspicious for recurrence.
QUESTION 2: Is there a role for advanced imaging for facial nerve detection preoperatively (eg, CISS/FIESTA or diffusion tensor imaging)?
TARGET POPULATION: Adults with proven or suspected vestibular schwannomas by imaging.
RECOMMENDATION: Level 3: T2-weighted MRI may be used to augment visualization of the facial nerve course as part of preoperative evaluation.
QUESTION 3: What is the expected growth rate of vestibular schwannomas on MRI, and how often should they be imaged if a "watch and wait" philosophy is pursued?
TARGET POPULATION: Adults with suspected vestibular schwannomas by imaging.
RECOMMENDATION: Level 3: MRIs should be obtained annually for 5 yr, with interval lengthening thereafter with tumor stability.
QUESTION 4: Do cystic vestibular schwannomas behave differently than their solid counterparts?
TARGET POPULATION: Adults with vestibular schwannomas with cystic components.
RECOMMENDATION: Level 3: Adults with cystic vestibular schwannomas should be counseled that their tumors may more often be associated with rapid growth, lower rates of complete resection, and facial nerve outcomes that may be inferior in the immediate postoperative period but similar to noncystic schwannomas over time.
QUESTION 5: Should the extent of lateral internal auditory canal involvement be considered by treating physicians?
TARGET POPULATION: Adult patients with vestibular schwannomas.
RECOMMENDATION: Level 3: The degree of lateral internal auditory canal involvement by tumor adversely affects facial nerve and hearing outcomes and should be emphasized when interpreting imaging for preoperative planning.
QUESTION 6: How should patients with neurofibromatosis type 2 (NF2) and vestibular schwannoma be imaged and over what follow-up period?
TARGET POPULATION: Adult patients with NF2 and vestibular schwannomas.
RECOMMENDATION: Level 3: In general, vestibular schwannomas associated with NF2 should be imaged (similar to sporadic schwannomas) with the following caveats: 1. More frequent imaging may be adopted in NF2 patients because of a more variable growth rate for vestibular schwannomas, and annual imaging may ensue once the growth rate is established. 2. In NF2 patients with bilateral vestibular schwannomas, growth rate of a vestibular schwannoma may increase after resection of the contralateral tumor, and therefore, more frequent imaging may be indicated, based on the nonoperated tumor's historical rate of growth. 3. Careful consideration should be given to whether contrast is necessary in follow-up studies or if high-resolution T2 (including CISS or FIESTA-type sequences) MRI may adequately characterize changes in lesion size instead.
QUESTION 7: How long should vestibular schwannomas be imaged after surgery, including after gross-total, near-total, and subtotal resection?
TARGET POPULATION: Adult patients with vestibular schwannomas followed after surgery.
RECOMMENDATION: Level 3: For patients receiving gross total resection, a postoperative MRI may be considered to document the surgical impression and may occur as late as 1 yr after surgery. For patients not receiving gross total resection, more frequent surveillance scans are suggested; annual MRI scans may be reasonable for 5 yr. Imaging follow-up should be adjusted accordingly for continued surveillance if any change in nodular enhancement is demonstrated. The full guideline can be found at https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter_5.
引用
- Dunn IF, Bi WL, Mukundan S, et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients With Vestibular Schwannomas. Neurosurgery. 2018. PMID: 29309686. doi:10.1093/neuros/nyx510
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。